[HTML][HTML] Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D

F Welander, H Renlund, E Dimény, H Holmberg… - Thrombosis …, 2023 - Elsevier
Introduction Warfarin treatment quality is calculated as time in therapeutic range (TTR).
TTR≥ 70% is considered reducing the risk of adverse events for patients with atrial …

Biomarkers for atrial fibrillation and chronic kidney disease: what is the evidence?

R Krittayaphong, K Methavigul - Polish Heart Journal …, 2021 - journals.viamedica.pl
Atrial fibrillation (AF) and chronic kidney disease (CKD) are a bad combination which leads
to an increased risk of ischemic stroke and major bleeding [1]. Although CKD and …

Gastrointestinale Blutungen unter Plättchenhemmung und Antikoagulation unter Berücksichtigung verschiedener Wirkstoffe und Kombinationen

C Roxlau - 2022 - refubium.fu-berlin.de
In dieser Studie waren in hohem Maße hochbetagte multimorbide Patienten von
gastrointestinaler Blutung unter antithrombotischer Vortherapie betroffen. Vortherapie mit …